
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 323
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 323
Showing 76-100 of 323 citing articles:
Study on the clinical characteristics, persistent infection capability, and viral load of human papillomavirus type 82 single infection
Zuyi Chen, Qimin Cheng, Xinyue Zhang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Zuyi Chen, Qimin Cheng, Xinyue Zhang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Pathogen priming alters host transmission potential and predictors of transmissibility in a wild songbird species
Ariel E. Leon, Arietta Fleming-Davies, James S. Adelman, et al.
mSphere (2025)
Open Access
Ariel E. Leon, Arietta Fleming-Davies, James S. Adelman, et al.
mSphere (2025)
Open Access
Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus
Ana A. Weil, Kyle G Luiten, Amanda M. Casto, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Ana A. Weil, Kyle G Luiten, Amanda M. Casto, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021–February 2022
Mircea T. Sofonea, Bénédicte Roquebert, Vincent Foulongne, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 7, pp. 1355-1365
Open Access | Times Cited: 25
Mircea T. Sofonea, Bénédicte Roquebert, Vincent Foulongne, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 7, pp. 1355-1365
Open Access | Times Cited: 25
Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant
Théophile Cocherie, Mathilda Bastide, Soraya Sakhi, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 24
Théophile Cocherie, Mathilda Bastide, Soraya Sakhi, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 24
Identifiability of parameters in mathematical models of SARS-CoV-2 infections in humans
Stanca M. Ciupe, Necibe Tuncer
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Stanca M. Ciupe, Necibe Tuncer
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Size distribution and relationship of airborne SARS-CoV-2 RNA to indoor aerosol in hospital ward environments
Veronika Groma, Szilvia Kugler, Árpád Farkas, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Veronika Groma, Szilvia Kugler, Árpád Farkas, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
Debra Van Egeren, Madison Stoddard, Laura F. White, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 853-853
Open Access | Times Cited: 13
Debra Van Egeren, Madison Stoddard, Laura F. White, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 853-853
Open Access | Times Cited: 13
SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier
Chiara Stüdle, Hideaki Nishihara, Sven Wischnewski, et al.
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Chiara Stüdle, Hideaki Nishihara, Sven Wischnewski, et al.
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 13
The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April–May 2022
Saba A Qasmieh, McKaylee Robertson, Chloe A. Teasdale, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 12
Saba A Qasmieh, McKaylee Robertson, Chloe A. Teasdale, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 12
Causes and costs of global COVID-19 vaccine inequity
Maddalena Ferranna
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 469-480
Open Access | Times Cited: 12
Maddalena Ferranna
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 469-480
Open Access | Times Cited: 12
COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
Dorota Zarębska‐Michaluk, Chenlin Hu, Michał Brzdęk, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1223-1223
Open Access | Times Cited: 20
Dorota Zarębska‐Michaluk, Chenlin Hu, Michał Brzdęk, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1223-1223
Open Access | Times Cited: 20
Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era
Federica Armas, Franciscus Chandra, Wei Lin Lee, et al.
Environment International (2022) Vol. 171, pp. 107718-107718
Open Access | Times Cited: 20
Federica Armas, Franciscus Chandra, Wei Lin Lee, et al.
Environment International (2022) Vol. 171, pp. 107718-107718
Open Access | Times Cited: 20
Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2221-2221
Open Access | Times Cited: 19
Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2221-2221
Open Access | Times Cited: 19
Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases
Antonio Lentini, Antonio Pereira, Ola Winqvist, et al.
Med (2022) Vol. 3, Iss. 9, pp. 636-643.e4
Open Access | Times Cited: 18
Antonio Lentini, Antonio Pereira, Ola Winqvist, et al.
Med (2022) Vol. 3, Iss. 9, pp. 636-643.e4
Open Access | Times Cited: 18
Comparison of antibody responses to SARS-CoV-2 variants in Australian children
Zheng Quan Toh, Nadia Mazarakis, Jill Nguyen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Zheng Quan Toh, Nadia Mazarakis, Jill Nguyen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Key Essentials during the Transition from the Acute Phase of the COVID-19 Pandemic
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 10
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 10
Comparison of infection severity of vaccinated and unvaccinated health workers with Corona Virus: A cohort study
Alaa Yousif Ayed, Nasir M. Younis, Mahmoud M. Ahmed
Journal of Education and Health Promotion (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Alaa Yousif Ayed, Nasir M. Younis, Mahmoud M. Ahmed
Journal of Education and Health Promotion (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses
Olha Puhach, Mathilde Bellon, Kenneth Adea, et al.
EBioMedicine (2023) Vol. 98, pp. 104893-104893
Open Access | Times Cited: 10
Olha Puhach, Mathilde Bellon, Kenneth Adea, et al.
EBioMedicine (2023) Vol. 98, pp. 104893-104893
Open Access | Times Cited: 10
Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity
Fridah Mwendwa, Akbar Kanji, Ali Raza Bukhari, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 6, pp. 1100-1107
Open Access | Times Cited: 3
Fridah Mwendwa, Akbar Kanji, Ali Raza Bukhari, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 6, pp. 1100-1107
Open Access | Times Cited: 3
Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity
Sunil J. Wimalawansa
Heliyon (2024) Vol. 10, Iss. 15, pp. e34691-e34691
Open Access | Times Cited: 3
Sunil J. Wimalawansa
Heliyon (2024) Vol. 10, Iss. 15, pp. e34691-e34691
Open Access | Times Cited: 3
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
Ankita Leekha, Arash Saeedi, K M Samiur Rahman Sefat, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Ankita Leekha, Arash Saeedi, K M Samiur Rahman Sefat, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
Eric A. Meyerowitz, Aaron Richterman
Infectious Disease Clinics of North America (2022) Vol. 36, Iss. 2, pp. 267-293
Open Access | Times Cited: 17
Eric A. Meyerowitz, Aaron Richterman
Infectious Disease Clinics of North America (2022) Vol. 36, Iss. 2, pp. 267-293
Open Access | Times Cited: 17
The unmitigated profile of COVID-19 infectiousness
Ron Sender, Yinon M. Bar-On, Sang Woo Park, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 17
Ron Sender, Yinon M. Bar-On, Sang Woo Park, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 17
A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology
Yongqun He, Hong Yu, Anthony Huffman, et al.
Journal of Biomedical Semantics (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Yongqun He, Hong Yu, Anthony Huffman, et al.
Journal of Biomedical Semantics (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16